The evolution of library design: crafting smart compound collections for phenotypic screens

Kell, 2013, Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it, FEBS J, 280, 5957, 10.1111/febs.12268 Shakespeare W. The Tempest. Act 2, Scene1. Schnur, 2008, Recent trends in library design: ‘Rational design’ revisited, Curr Opin Drug Discov Dev, 11, 375 Paricharak, 2016, Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening, Brief Bioinform, 10.1093/bib/bbw105 Mignani, 2016, Compound high-quality criteria: a new vision to guide the development of drugs, current situation, Drug Discov Today, 21, 573, 10.1016/j.drudis.2016.01.005 Zuegg, 2012, Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening, Curr Top Med Chem, 12, 1500, 10.2174/156802612802652466 Senger, 2016, Filtering promiscuous compounds in early drug discovery: is it a good idea, Drug Discov Today, 21, 868, 10.1016/j.drudis.2016.02.004 Miller, 2006, Recent developments in focused library design: targeting gene-families, Curr Top Med Chem, 6, 19, 10.2174/156802606775193347 Petrone, 2013, Biodiversity of small molecules—a new perspective in screening set selection, Drug Discov Today, 18, 674, 10.1016/j.drudis.2013.02.005 Rizzo, 2014, Development of a natural-product-derived chemical toolbox for modulation of protein function, Chem Rev, 114, 4621, 10.1021/cr400442v Wender, 2015, Function through synthesis-informed design, Acc Chem Res, 48, 752, 10.1021/acs.accounts.5b00004 Doak, 2016, The ways and means of fragment-based design, Pharmacol Ther, 167, 28, 10.1016/j.pharmthera.2016.07.003 Vela, 2016, Discovery of enhancers of the secretion of leukemia inhibitory factor for the treatment of multiple sclerosis, J Biomol Screen, 21, 437, 10.1177/1087057116638821 Tschapalda, 2016, A class of diacylglycerol acyltransferase1 inhibitors identified by a combination of phenotypic high-throughput screening, genomics and genetics, EBioMedicine, 8, 49, 10.1016/j.ebiom.2016.04.014 Houghten, 2016, Direct phenotypic screening in mice: identification of individual, novel antinociceptive compounds from a library of 734821 pyrrolidine bis-piperazines, ACS Comb Sci, 18, 51, 10.1021/acscombsci.5b00126 Shao, 2016, In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents, MedChemComm, 7, 1093, 10.1039/C6MD00128A Geldenhuis, 2017, High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitor, Bioorg Med Chem Lett, 27, 2029, 10.1016/j.bmcl.2017.02.068 Van Voorhis, 2016, Open source drug discovery with the malaria box collection for neglected diseases and beyond, PLOS Pathog, 12, e1005763, 10.1371/journal.ppat.1005763 Hostettler, 2016, In vitro screening of the open source MMV malaria box reveals novel compounds with profound activities against Theileria annulata schizonts, Antimicrob Agents Chemother, 60, 3301, 10.1128/AAC.02801-15 McShane, 2015, A combination of screening and computational approaches for the identification of novel compounds that decrease mast cell degranulation, J Biomol Screen, 20, 720, 10.1177/1087057115579613 Paunovic, 2017, Phenotypic screen for cardiac regeneration identifies molecules with differential activity in human epicardium-derived cells versus cardiac fibroblasts, ACS Chem Biol, 12, 132, 10.1021/acschembio.6b00683 Keller, 2011, Anti-infectives: can cellular screening deliver?, Curr Opin Chem Biol, 15, 529, 10.1016/j.cbpa.2011.06.007 Clemons, 2010, Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles, Proc Natl Acad Sci U S A, 107, 18787, 10.1073/pnas.1012741107 Nilar, 2013, The importance of molecular complexity in the design of screening libraries, J Comput Aided Mol Des, 27, 783, 10.1007/s10822-013-9683-1 Meyers, 2016, On the origins of three-dimensionality in drug-like molecules, Future Med Chem, 8, 1753, 10.4155/fmc-2016-0095 Foley, 2016, Evaluating new chemistry to drive molecular discovery: fit for purpose, Angew Chem Int Ed Engl, 55, 13650, 10.1002/anie.201604193 Comer, 2014, Utilizing diversity-oriented synthesis in antimicrobial research, Future Med Chem, 6, 1927, 10.4155/fmc.14.111 Bathula, 2015, Diversity oriented synthesis for novel anti-malarials, Syst Synth Biol, 9, 49, 10.1007/s11693-015-9171-0 Nagiec, 2015, Modulators of hepatic lipoprotein metabolism identified in a search for small molecule inducers of tribbles pseudokinase 1 expression, PLoS One, 10, e0120295, 10.1371/journal.pone.0120295 Duvall, 2016, Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen, Antiviral Res, 131, 19, 10.1016/j.antiviral.2016.03.015 Kato, 2016, Diversity-oriented synthesis yields novel multistage antimalarial inhibitors, Nature, 538, 344, 10.1038/nature19804 Xiang, 2016, Discovery of novel tricyclic thiazepine derivatives as anti-drug-resistant cancer agents by combining diversity-oriented synthesis and converging screening approach, ACS Comb Sci, 18, 230, 10.1021/acscombsci.6b00010 Wu, 2016, Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship, Eur J Med Chem, 115, 141, 10.1016/j.ejmech.2016.03.039 Maier, 2015, Design and synthesis of analogues of natural products, Org Biomol Chem, 13, 5302, 10.1039/C5OB00169B Crane, 2016, Capturing biological activity in natural product fragments by chemical synthesis, Angew Chem Int Ed Engl, 55, 3882, 10.1002/anie.201505863 Miyao, 2015, Chemography of natural product space, Planta Med, 81429 Lipinski, 2016, Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions, Adv Drug Deliv Rev, 101, 34, 10.1016/j.addr.2016.04.029 Rodrigues, 2016, Counting of natural products for drug design, Nat Chem, 8, 531, 10.1038/nchem.2479 van Hattum, 2014, Biology-oriented synthesis: harnessing the power of evolution, J Am Chem Soc, 136, 11853, 10.1021/ja505861d Svenda, 2015, Biology-oriented synthesis of a withanolide-inspired compound collection reveals novel modulators of hedgehog signaling, Angew Chem Int Ed Engl, 54, 5596, 10.1002/anie.201500112 Schroeder, 2016, Synthesis of an iridoid-inspired compound collection and the discovery of autophagy inhibitors, J Org Chem, 81, 10242, 10.1021/acs.joc.6b01185 Wang, 2015, Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents, J Med Chem, 58, 6678, 10.1021/acs.jmedchem.5b00910 Over, 2013, Natural-product-derived fragments for fragment-based ligand discovery, Nature Chem, 5, 21, 10.1038/nchem.1506 Pascolutti, 2015, Capturing nature’s diversity, PLoS One, 10, e0120942, 10.1371/journal.pone.0120942 Yu, 2016, Natural product-derived spirooxindole fragments serve as privileged substructures for discovery of new anticancer agents, Anticancer Agents Med Chem, 16, 1, 10.2174/1871520615666151102093825 Hela, 2016, Public domain HTS fingerprints: design and evaluation of compound bioactivity profiles from PubChem’s bioassay repository, J Chem Inf Model, 56, 390, 10.1021/acs.jcim.5b00498 Ekins, 2015, Machine learning models and pathway genome data base for Trypanosoma cruzi drug discovery, PLoS Negl Trop Dis, 9, e0003878, 10.1371/journal.pntd.0003878 Wawer, 2014, Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling, Proc Natl Acad Sci U S A, 111, 10911, 10.1073/pnas.1410933111